|
.
See Category: Neoplasms
ICD-10 (CM) Code and Descriptor
C33 |
Malignant neoplasm of trachea
|
C33 utilizaton on OPPS claims.*
Primary ICD10 Code |
ICD10 Position 2 |
ICD10 Position 3 |
ICD10 Position 4 |
ICD10 Position 5 |
ICD10 Position 6 |
ICD10 Position 7 |
ICD10 Position 8 |
ICD10 Position 9 |
ICD10 Position 10 |
53.62%
|
23.12%
|
10.37%
|
5.13%
|
2.73%
|
1.56%
|
1.38%
|
0.49%
|
0.41%
|
0.21%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C33*:
CPT |
Description |
Number of Claims |
Sum Performed |
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
973
|
986
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
898
|
899
|
80053
|
COMPREHEN METABOLIC PANEL |
841
|
842
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
556
|
563
|
77386
|
NTSTY MODUL RAD TX DLVR CPLX |
417
|
419
|
G1004
|
CDSM NDSC |
371
|
427
|
96413
|
CHEMO IV INFUSION 1 HR |
337
|
337
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
323
|
31,970
|
71260
|
CT THORAX DX C+ |
314
|
314
|
84443
|
ASSAY THYROID STIM HORMONE |
310
|
311
|
Q3014
|
TELEHEALTH FACILITY FEE |
296
|
301
|
J1100
|
DEXAMETHASONE SODIUM PHOS |
196
|
2,035
|
88305
|
TISSUE EXAM BY PATHOLOGIST |
172
|
283
|
J2704
|
INJ, PROPOFOL, 10 MG |
172
|
5,967
|
J2405
|
ONDANSETRON HCL INJECTION |
167
|
1,092
|
82565
|
ASSAY OF CREATININE |
157
|
160
|
83735
|
ASSAY OF MAGNESIUM |
138
|
138
|
84439
|
ASSAY OF FREE THYROXINE |
137
|
137
|
J3010
|
FENTANYL CITRATE INJECTION |
136
|
207
|
J9271
|
INJ PEMBROLIZUMAB |
135
|
30,400
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C33 related to the following DRG Codes:
180-182
|